Dainippon Sumitomo Pharma
Overview
Dainippon Sumitomo Pharma is a leading pharmaceutical company that develops a wide range of drugs and therapies. With a strong focus on innovation, the company aims to address unmet medical needs in various therapeutic areas. As a subsidiary of Sumitomo Chemical, it leverages robust research and development capabilities.
Active pharmaceutical ingredients supplied
Substances Dainippon Sumitomo Pharma is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.
API / Drug Master Files
Dainippon Sumitomo Pharma holds 0 active (5 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- SMP-601 DRUG SUBSTANCEInactive2007-11-07
- SMP-028Inactive2005-12-15
- SMP-114Inactive2005-08-08
- SMP-797 DRUG SUBSTANCEInactive2005-03-02
- MEROPENEM/SODIUM CARBONATEInactive1993-06-25
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Dainippon Sumitomo Pharma in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Dainippon Sumitomo Pharma? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.